查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
COVID-19 癌症免疫治疗市场影响分析，按技术类型、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1335289

COVID-19 癌症免疫治疗市场影响分析，按技术类型、按应用、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Cancer Immunotherapy Market with COVID-19 Impact Analysis, By Technology Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 321 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年癌症免疫治疗市场规模为 879.086 亿美元，2023 年至 2030 年復合年增长率为 13.8%。

癌症免疫治疗市场-市场动态：

  • 癌症发病率的不断上升和癌症治疗技术进步的激增预计将推动全球癌症免疫治疗市场的增长。
  • 不断扩大的癌症负担迫切需要更有效和量身定制的治疗替代方案。癌症免疫疗法在治疗多种类型的癌症方面已显示出令人鼓舞的结果，并逐渐被视为现代癌症治疗技术的重要组成部分。根据美国疾病控制与预防中心的数据，2020年美国报告新增癌症病例1,603,844例，602,347人死于癌症。每10万人中，新增癌症病例403例，144人死于癌症。 2020 年是可获得发病率数据的最新一年。癌症研究领域的快速技术进步催生了新型定製药物的诞生。尤其是免疫疗法，随着免疫检查点抑製剂、CAR-T 细胞疗法、癌症疫苗、溶瘤病毒和其他创新技术的出现，已经取得了相当大的进展。随着新兴国家医疗保健基础设施的加速发展，癌症免疫疗法将有更多的机会被采用。然而，高昂的费用可能会阻止许多患者获得癌症免疫治疗，特别是在不太富裕的国家或地区。

癌症免疫治疗市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球癌症免疫治疗市场在预测期内（2023-2030）每年将以 13.8% 左右的复合年增长率增长
  • 由于人们对可持续增长的认识不断增强，癌症免疫治疗行业预计将以显着的速度增长
  • 根据产品类型细分，预计单克隆抗体将在 2022 年呈现最大市场份额
  • 根据应用细分，2022年肺癌为主导类型
  • 根据最终用户细分，医院是 2022 年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

癌症免疫治疗市场-細項分析：

  • 全球癌症免疫治疗市场根据产品类型、应用、最终用户和地区进行细分。
  • 根据产品类型，市场分为三类：单克隆抗体、细胞因子和免疫调节剂以及其他。单克隆抗体在市场上占据主导地位。单克隆抗体（mAb）是一种癌症免疫疗法，已成为治疗各种癌症的重要组成部分。这些是实验室製造的化合物，可以模仿免疫系统对抗癌细胞等危险感染的能力。
  • 根据应用，市场分为六类：肺癌、乳腺癌、结直肠癌、黑色素瘤、前列腺癌、头颈癌等。肺癌在市场上占据主导地位，并可能在预测期内保持其主导地位。免疫疗法已成为肺癌治疗方案的重要补充。多年来，化疗和放疗是肺癌的主要治疗选择。
  • 根据最终用户，市场分为三类：医院、癌症研究中心和诊所。医院领域主导着市场增长。癌症免疫疗法广泛应用于世界各地的医院和诊所，从小医院到大型大学医疗机构。

癌症免疫治疗市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。由于医疗保健支出增加、癌症发病率上升以及获得医疗保险的人数激增，预计北美将主导市场增长。北美，尤其是美国，人均医疗保健支出比世界上任何其他国家都多。由于这种高水平的支出，公共和商业部门都可以投资于新颖且通常昂贵的癌症治疗方法，例如免疫疗法。根据美国医学会的数据，2021 年美国医疗保健支出增长 2.7%，达到 4.3 万亿美元，即人均 12,914 美元。健康保险的可用性会对患者接受及时和高质量护理的能力产生重大影响。由于该地区基础设施的发展和癌症发病率的上升，欧洲是市场增长的第二大地区。

癌症免疫治疗市场-竞争格局：

全球范围内不断扩大的癌症负担以及免疫疗法在治疗特定形式癌症方面的既定疗效增加了对癌症免疫疗法的需求。该行业的公司经常在一些因素上展开竞争，例如特定疗法的功效和安全性、其药物可治疗的恶性肿瘤范围、定价以及向消费者展示其疗法价值的能力。他们也在研发管线方面展开竞争，因为新药和适应症可以提供竞争优势。近年来，该领域出现了重大创新，导致了新疗法和技术的发展。例如，2022 年 11 月，辉瑞公司宣布其在研癌症免疫疗法 elranatamab 获得美国食品和药物管理局 (FDA) 的突破性疗法认定，用于治疗復发或难治性多发性骨髓瘤 (RRMM) 患者。

最近的发展：

2023 年6 月，默克公司（在美国和加拿大境外称为MSD）宣布，美国食品和药物管理局(FDA) 已接受新的补充生物製剂许可申请(sBLA) 的审查，该申请寻求批准默克公司的抗PD 药物KEYTRUDA -1 疗法与标准护理化疗相结合，用于治疗局部晚期不可逆或转移性胆道癌 (BTC) 患者。

该研究的主要特点：

  • 这项关于癌症免疫治疗市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年
  • 该报告为客户提供了有关癌症免疫治疗市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了癌症免疫治疗市场有吸引力的投资主张矩阵
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及癌症免疫治疗市场维持的增长因素
  • COVID-19 对癌症免疫治疗市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将涵盖对新冠疫情后癌症免疫治疗市场的详细见解。
  • 为了让本报告的用户全面了解癌症免疫治疗市场，我们还包括了癌症免疫治疗市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这将帮助用户了解在癌症免疫治疗市场运营的参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球癌症免疫治疗市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师

目录

第一章：癌症免疫治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按技术类型分類的癌症免疫治疗市场片段
    • 癌症免疫治疗市场片段（按应用）
    • 最终用户的癌症免疫治疗市场片段
    • 按国家/地区分類的癌症免疫治疗市场片段
    • 按地区分類的癌症免疫治疗市场片段
  • 竞争洞察

第 3 章：癌症免疫治疗主要市场趋势

  • 癌症免疫治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 癌症免疫治疗市场限制
    • 市场限制影响分析
  • 癌症免疫治疗市场机会
  • 癌症免疫治疗市场未来趋势

第 4 章：癌症免疫治疗行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：癌症免疫治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：癌症免疫治疗市场格局

  • 2022 年癌症免疫治疗市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：癌症免疫治疗市场 - 按技术类型

  • 概述
    • 按技术类型分類的细分市场份额分析
    • 单克隆抗体
    • 细胞因子和免疫调节剂
    • 其他的

第 8 章：癌症免疫治疗市场 -按应用

  • 概述
    • 按应用的细分市场份额分析
    • 肺癌
    • 乳癌
    • 结直肠癌
    • 黑色素瘤
    • 前列腺癌
    • 头颈癌
    • 其他的

第 9 章：癌症免疫治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场份额分析
    • 医院
    • 癌症研究中心
    • 诊所

第 10 章：癌症免疫治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美癌症免疫疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症免疫疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按技术类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区癌症免疫疗法主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按技术类型）
    • 亚太地区市场规模和预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲癌症免疫疗法主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按技术类型）
    • 拉丁美洲市场规模和预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲癌症免疫疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-癌症免疫治疗行业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • AstraZeneca
    • Merck & Co., Inc
    • F. Hoffmann-La Roche Ltd
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Lilly
    • Johnson & Johnson Services, Inc
    • Immunocore, Ltd

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1564

REPORT HIGHLIGHT

The Cancer Immunotherapy Market size was valued at USD 87,908.6 Million in 2022, expanding at a CAGR of 13.8% from 2023 to 2030.

Cancer immunotherapy is a sort of cancer treatment that uses the body's own immune system to combat cancer. It works by assisting the immune system in recognizing and attacking cancer cells. Immunotherapy can be used alone or in conjunction with other cancer treatments. Cancer frequently overcomes many of the immune system's natural defenses, allowing cancer cells to proliferate. Different types of immunotherapy work in different ways. Some immunotherapy treatments assist the immune system block or limiting the growth of cancer cells. Others aid the immune system in destroying cancer cells or preventing cancer from spreading to other parts of the body. Immunotherapy has shown promise in treating a variety of cancers and has become a major focus of cancer research.

Cancer Immunotherapy Market- Market Dynamics:

  • The growing incidence of cancer and the surge in technological advancements in cancer treatment therapies are expected to propel the growth of the global cancer immunotherapy market.
  • The expanding cancer burden has produced a critical demand for more effective and tailored treatment alternatives. Cancer immunotherapy has demonstrated encouraging outcomes in treating several types of cancer and is gradually being regarded as an important component of modern cancer treatment techniques. According to the Centers for disease control and Prevention, In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available. Rapid technological advances in cancer research have resulted in the creation of novel and tailored medicines. Immunotherapy, in particular, has made considerable advances in recognition of the advent of immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, oncolytic viruses, and other innovative techniques. As healthcare infrastructure in emerging nations accelerates, there will be greater opportunities for cancer immunotherapies to be adopted. However, High expenses can prevent many patients from gaining Cancer Immunotherapy, particularly in less rich nations or regions.

Cancer Immunotherapy Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Cancer Immunotherapy market is estimated to grow annually at a CAGR of around 13.8% over the forecast period (2023-2030)
  • The Cancer Immunotherapy industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Lung Cancer was the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Cancer Immunotherapy Market- Segmentation Analysis:

  • The Global Cancer Immunotherapy Market is segmented on the basis of Product Type, Application, End-User, and Region.
  • The market is divided into three categories based on product type: Monoclonal Antibodies, Cytokines & Immunomodulators, and Others. Monoclonal Antibodies dominate the market. Monoclonal antibodies (mAbs) are a type of cancer immunotherapy that has become an essential component in the treatment of various cancers. These are lab-created compounds that can imitate the immune system's ability to combat dangerous infections such as cancer cells.
  • The market is divided into six categories based on application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others. Lung Cancer dominates the market and is likely to maintain its dominance during the forecast period. Immunotherapy has emerged as an important complement to lung cancer treatment options. Chemotherapy and radiation were the principal treatment choices for lung cancer for many years.
  • The market is divided into three categories based on End-User: Hospitals, Cancer Research Centers, and Clinics. The hospital segment dominates the market growth. Cancer immunotherapy is widely employed in hospitals and clinics all over the world, from small hospitals to large university medical institutes.

Cancer Immunotherapy Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, owing to an increase in healthcare expenditure, a rise in the incidence of cancer, and a surge in access to medical insurance. North America, especially the United States, spends more per capita on healthcare than any other country in the world. Because of this high level of spending, both the public and commercial sectors can invest in novel and frequently expensive cancer treatments, such as immunotherapies. According to American Medical Association, Health spending in the U.S. increased by 2.7% in 2021 to USD 4.3 trillion or USD12,914 per capita. The availability of health insurance can have a substantial impact on a patient's capacity to receive timely and high-quality care. Europe is the second largest region for the growth of the market, owing to the development in the infrastructure in the region and rising incidences of cancer.

Cancer Immunotherapy Market- Competitive Landscape:

The expanding worldwide burden of cancer and the established efficacy of immunotherapies in treating specific forms of cancer have increased the demand for cancer immunotherapy. Companies in this industry frequently compete on factors such as particular treatments' efficacy and safety profile, the spectrum of malignancies their medications can treat, pricing, and their ability to demonstrate the value of their therapies to consumers. They compete in terms of their R&D pipelines as well, as novel medicines and indications can provide a competitive advantage. This field has seen major innovation in recent years, leading to the development of new therapies and techniques. For example, on November 2022, Pfizer Inc. nowadays announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of people with relapsed or refractory multiple myeloma (RRMM).

Recent Developments:

On June 2023, Merck, known as MSD outside of the United States and Canada, nowadays announced the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA, Merck's anti-PD-1 therapy, in combination with standard of care chemotherapy for the treatment of patients with locally advanced unrespectable or metastatic biliary tract cancer (BTC).

Key features of the study:

  • This proposed research study on Cancer Immunotherapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Cancer Immunotherapy market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Immunotherapy market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Immunotherapy market
  • Impact of COVID-19 on Cancer Immunotherapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Immunotherapy market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Cancer Immunotherapy market, we have also included competitive landscape and key innovator analysis for the Cancer Immunotherapy market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cancer Immunotherapy market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Cancer Immunotherapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMMUNOTHERAPY MARKET KEY PLAYERS

  • Pfizer Inc.
  • AstraZeneca
  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Lilly
  • Johnson & Johnson Services, Inc
  • Immunocore, Ltd

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY TECHNOLOGY TYPE

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY APPLICATION

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY END-USER

  • Hospitals
  • Cancer Research Centers
  • Clinics

GLOBAL CANCER IMMUNOTHERAPY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Immunotherapy Market Snippet by Technology Type
    • 2.1.2. Cancer Immunotherapy Market Snippet by Application
    • 2.1.3. Cancer Immunotherapy Market Snippet by End-User
    • 2.1.4. Cancer Immunotherapy Market Snippet by Country
    • 2.1.5. Cancer Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Immunotherapy Key Market Trends

  • 3.1. Cancer Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Immunotherapy Market Opportunities
  • 3.4. Cancer Immunotherapy Market Future Trends

4. Cancer Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Immunotherapy Market Landscape

  • 6.1. Cancer Immunotherapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Immunotherapy Market - By Technology Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Cytokines & Immunomodulators
    • 7.1.4. Others

8. Cancer Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Lung Cancer
    • 8.1.3. Breast Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Melanoma
    • 8.1.6. Prostate Cancer
    • 8.1.7. Head & Neck Cancer
    • 8.1.8. Others

9. Cancer Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Cancer Research Centers
    • 9.1.4. Clinics

10. Cancer Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. AstraZeneca
    • 11.2.3. Merck & Co., Inc
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Novartis AG
    • 11.2.7. Lilly
    • 11.2.8. Johnson & Johnson Services, Inc
    • 11.2.9. Immunocore, Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Immunotherapy Market: Technology Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Cancer Immunotherapy Market, by Technology Type 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Immunotherapy Market, by Application 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cancer Immunotherapy Market, by End-User 2018-2030 (USD Million)
  • TABLE Cancer Immunotherapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Immunotherapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Technology Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Immunotherapy Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology Type segment market share analysis, 2022 & 2030
  • FIGURE Technology Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Europe Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Latin America Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Germany Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE India Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Brazil Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Immunotherapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Immunotherapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)